
ALT BioAI Frontier editorial cover with the headline Baker Lab × Green Lab and text Choose the C–H Site. Design the Enzyme. Supporting text states One Molecule. Two Target Sites. Estradiol: C6 or C16. Preprint, wet-lab validated. A stylized folded-protein pocket holding an amber substrate represents the design concept; this is an illustration, not a measured molecular structure.

ALT Original Figure 4: site-selective estradiol hydroxylation. A shows C6 hydroxylation to 6alpha-hydroxyestradiol or C16 hydroxylation to estriol. B shows 96 C6 designs and 67 C16 designs; initial yields were below 1% and about 1%, with 93% and >99% diastereomeric excess. C shows Q20N, W70K, I121V and V140Q substitutions increasing C16 yield to 37% and turnovers to 37 while retaining >99% d.e. D overlays the substrate-free, heme-bound dOHes-2-NKVQ crystal structure with the design, C-alpha RMSD 0.65 angstrom. These percentages for d.e. describe stereoselectivity, not yield. Source: Kalvet et al., bioRxiv (2026), Fig. 4, CC BY 4.0.

ALT Original Figure 1: design principles and workflow for de novo C-H hydroxylases. A-D show hydroxylation applications, oxygen/peroxide activation, the Glu-His dyad promoting heterolytic peroxide cleavage, and Compound I hydrogen abstraction and radical rebound. E-F show the minimal heme-based catalytic motif and target substrate geometry, RFdiffusion2/3 backbone generation, iterative LigandMPNN/Rosetta Relax sequence design, and Chai-1 or AlphaFold3 filtering. Original panels and labels retained. Source: Kalvet et al., bioRxiv (2026), Fig. 1, CC BY 4.0.
































